98 related articles for article (PubMed ID: 28647934)
1. Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.
Schayek H; Laitman Y; Katz LH; Pras E; Ries-Levavi L; Barak F; Friedman E
Isr Med Assoc J; 2017 Jun; 19(6):365-367. PubMed ID: 28647934
[TBL] [Abstract][Full Text] [Related]
2. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
[TBL] [Abstract][Full Text] [Related]
3. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
[TBL] [Abstract][Full Text] [Related]
5. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
[TBL] [Abstract][Full Text] [Related]
7. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
[TBL] [Abstract][Full Text] [Related]
8. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
9. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
Li L; Eng C; Desnick RJ; German J; Ellis NA
Mol Genet Metab; 1998 Aug; 64(4):286-90. PubMed ID: 9758720
[TBL] [Abstract][Full Text] [Related]
10. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
Roa BB; Savino CV; Richards CS
Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
12. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry.
Ellis NA; Ciocci S; Proytcheva M; Lennon D; Groden J; German J
Am J Hum Genet; 1998 Dec; 63(6):1685-93. PubMed ID: 9837821
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for the BLM(Ash) mutation and cancer risk.
Cleary SP; Zhang W; Di Nicola N; Aronson M; Aube J; Steinman A; Haddad R; Redston M; Gallinger S; Narod SA; Gryfe R
Cancer Res; 2003 Apr; 63(8):1769-71. PubMed ID: 12702560
[TBL] [Abstract][Full Text] [Related]
14. A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene.
Straughen JE; Johnson J; McLaren D; Proytcheva M; Ellis N; German J; Groden J
Hum Mutat; 1998; 11(2):175-8. PubMed ID: 9482582
[TBL] [Abstract][Full Text] [Related]
15. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
[TBL] [Abstract][Full Text] [Related]
16. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
Woodage T; King SM; Wacholder S; Hartge P; Struewing JP; McAdams M; Laken SJ; Tucker MA; Brody LC
Nat Genet; 1998 Sep; 20(1):62-5. PubMed ID: 9731533
[TBL] [Abstract][Full Text] [Related]
17. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
19. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.
Chen-Shtoyerman R; Figer A; Fidder HH; Rath P; Yeremin L; Bar Meir S; Friedman E; Theodor L
Br J Cancer; 2001 Feb; 84(4):475-7. PubMed ID: 11207040
[TBL] [Abstract][Full Text] [Related]
20. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
Drucker L; Stackievitz R; Shpitz B; Yarkoni S
Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
